Bupropion Tablet, Extended Release
Product Images NDC 63187-521

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 63187-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Extended-release Tablets, Usp (xl) (Bupropionxltablets Figure 01)

Chemical structure of bupropion hydrochloride showing a chlorophenyl group attached to a hydroxypropyl side chain with a tert-butylamino group.*

FDA Label Image

Image 01

Label for Bupropion HCl 300 mg extended-release tablets, once daily, in a quantity of 30 tablets. The label indicates the product ID RB052130 and states the tablets are creamy-white to pale-yellow, round, biconvex, coated, and imprinted with '354'. Manufactured by Cadila Healthcare Limited, India, and relabeled by Proficient Rx LP, Thousand Oaks, CA. Storage instructions and warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.